7+3 (MİTOKSANTRON) PROTOKOLÜ

Kaynaklar:

1- Arlin ZA, Case DC Jr, Moor J, Wiernik P, Feldaman E, Saletan S, et al. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia(ANLL). Leukemia, 1990;4: 177-83. 

2- Pavlovsky S, Gonzalez Llaren J, Garsia Martinez MA, Sobrevilla P, Eppinger-Helft M, Marin A, et al. A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute non lymphocytic leukemia. Ann Hematol 1994;69: 11-5.

3-Lowenberg, B., S. Suciu, E. Archimbaud, et al. 1998. "Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group." J Clin Oncol 16(3):872-881.